drugset / Trial / NCT02996409

High-Volume Image-Guided Injection in Chronic Midportion Achilles Tendinopathy

NCT02996409 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

Overuse injury of the Achilles tendon is a common entity in athletes. Currently, the usual treatment for chronic midportion Achilles tendinopathy is an eccentric exercise program. In most cases this gives satisfactory results, however there is a significant group of patients in which the exercise program is not sufficient. Prior to our study, three United Kingdom based studies have investigated the efficacy of High-Volume Image-Guided Injections (HVIGI's) in chronic midportion Achilles tendinopathy. They all showed promising results. However none of these studies had an adequate control group. This double-blind, placebo-controlled, randomized clinical trial will investigate the value of a High-Volume Image-Guided Injection in chronic midportion Achilles tendinopathy.

Timeline

Start
2016-12
Primary completion
2019-07
Completion
2019-07

Drugs

EvaluationDrugModalityDoseRoute
Background Lidocaine Other / unclassified 0.4 ml Other
Background Lidocaine Other / unclassified 10 ml Other

Indications